Answers are grounded in this paper and cite their sources.
PURPOSE OF REVIEW: Interventional pain management is an emerging specialty that uses procedures to diagnose and treat chronic pain. Most of these procedures are performed percutaneously and carry a risk of bleeding. Patients undergoing these treatments may be receiving exogenous anticoagulants. The pain practitioner faces a dilemma in performing an elective procedure on a patient with a bleeding risk. RECENT FINDINGS: A literature review about coagulation physiology and pathophysiology, anticoagulants, and bleeding complications in interventional pain would be useful to a busy pain physician. This review aims to meet this knowledge goal. SUMMARY: Knowledge about normal and impaired hemostasis, coupled with a bleeding risk tool, enables practitioners to make informed decisions when offering interventional pain care to their patients.
No takes yet. Share an insight, caveat, or question.
Shah et al. (2008) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: